Alarmingly High Rates of Deep Vein Thrombosis and Pulmonary Embolism Following Closed Reduction for Dislocated Total Hip Arthroplasty
- PMID: 39551412
- DOI: 10.1016/j.arth.2024.11.020
Alarmingly High Rates of Deep Vein Thrombosis and Pulmonary Embolism Following Closed Reduction for Dislocated Total Hip Arthroplasty
Abstract
Background: Venous thromboembolism (VTE) and dislocation are well-described complications following total hip arthroplasty (THA). However, the relationship between THA dislocation and venous thromboembolism remains unclear. This study sought to determine the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients who experience a hip dislocation and subsequent closed reduction following primary THA.
Methods: All primary THA patients were identified in an inpatient admissions database. The THA patients who had a dislocation within 90 days of surgery who were treated with closed reduction were compared to patients who did not dislocate within 90 days of surgery. Differences in patient demographics, comorbidities, hospital characteristics, postoperative chemoprophylactic agents, and 90-day postoperative infectious rates were calculated between the cohorts. Univariate and multivariable regression were used to assess the impact of THA dislocation treated with closed reduction on 90-day DVT and PE risk.
Results: There were 550,208 primary THAs identified. Of these patients, 3,700 (0.7%) experienced a dislocation within 90 days, of which 2,487 (67.2%) were treated with closed reduction. Patients who dislocated and underwent closed reduction had increased rates of PE (0.9 versus 0.3%, P < 0.001) and DVT (1.6 versus 0.5%, P < 0.001) compared to patients who did not dislocate. After controlling for confounding factors, patients in the closed reduction group had elevated risks of both DVT (adjusted odds ratio [aOR] 2.5, 95% confidence interval [CI]: 1.8 to 3.4, P < 0.001) and PE (aOR 2.2, 95% CI: 1.4 to 3.3, P < 0.001).
Discussion: Patients who undergo closed reduction for dislocation following primary THA have an alarmingly high risk of DVT and PE. These findings should prompt surgeons to consider chemoprophylaxis among patients who experience a dislocation, even when treated with a closed reduction.
Keywords: closed reduction; deep vein thrombosis; dislocation; pulmonary embolism; total hip arthroplasty; total joint arthroplasty.
Copyright © 2024 Elsevier Inc. All rights reserved.
Similar articles
-
Risk Factors Associated with Thromboembolic Complications After total Hip Arthroplasty: An Analysis of 1,129 Pulmonary Emboli.J Am Acad Orthop Surg. 2024 Jul 15;32(14):e706-e715. doi: 10.5435/JAAOS-D-23-01213. Epub 2024 Apr 10. J Am Acad Orthop Surg. 2024. PMID: 38626438
-
Is Obesity Associated With Increased Risk of Deep Vein Thrombosis or Pulmonary Embolism After Hip and Knee Arthroplasty? A Large Database Study.Clin Orthop Relat Res. 2019 Mar;477(3):523-532. doi: 10.1097/CORR.0000000000000615. Clin Orthop Relat Res. 2019. PMID: 30624321 Free PMC article.
-
Perioperative Dexamethasone is Associated With a Decreased Risk of Pulmonary Embolism and Deep Vein Thrombosis Following Total Joint Arthroplasty: An Analysis of 70,000 High-Risk Patients.J Arthroplasty. 2024 Oct;39(10):2446-2451.e1. doi: 10.1016/j.arth.2024.05.020. Epub 2024 May 10. J Arthroplasty. 2024. PMID: 38735549
-
Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis.Medicine (Baltimore). 2019 Mar;98(9):e14539. doi: 10.1097/MD.0000000000014539. Medicine (Baltimore). 2019. PMID: 30817570 Free PMC article.
-
Factors related to deep vein thrombosis as a complication of post-total hip arthroplasty patients: a systematic review.Eur J Orthop Surg Traumatol. 2025 Feb 28;35(1):82. doi: 10.1007/s00590-025-04209-4. Eur J Orthop Surg Traumatol. 2025. PMID: 40021493
MeSH terms
LinkOut - more resources
Full Text Sources
Medical